Result: Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2021

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

Trials. - 22, 1 (2021) , 343, ISSN: 1745-6215

*DOI*:

10.1186/s13063-021-05181-0

*Result*: Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial